# European Innovation Council

> European Innovation Council is a VC fund backing Health Care. See 1,175 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Brussels, Belgium
- Total investments: 1,175
- Last investment: Jul 2026
- Lead investor: 74%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/eismea
- X (Twitter): https://twitter.com/EUeic
- Website: https://ec.europa.eu/research/eic/index.cfm
- Facebook: https://www.facebook.com/EIC-The-European-Innovation-Council-2462855093727279/

European Innovation Council is a VC fund in Brussels focused on Health Care and Biotechnology. The European Innovation Council aims to support top-class innovators, entrepreneurs, small companies, and researchers with bright ideas. The EIC co-invests alongside private investors in early-stage startups that have ESG impacts.

## Contacts

5 contacts available for European Innovation Council. Shizune tracks 21 team members at European Innovation Council. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/european-innovation-council?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 77 | 7% |
| Biotechnology | 66 | 6% |
| Medical Device | 55 | 5% |
| Medical | 44 | 4% |
| Software | 31 | 3% |

178 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 163 | 14% |
| Funding Round | 65 | 6% |
| Series A | 36 | 3% |
| Seed | 30 | 3% |
| Series B | 14 | 1% |

13 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 31 | 3% |
| Germany | 25 | 2% |
| The Netherlands | 24 | 2% |
| Israel | 23 | 2% |
| Switzerland | 23 | 2% |

29 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Baybars Altuntas | Board Member | 0 | https://shizune.co/investors/profile/baybars-altuntas |
| Candace Johnson | President | 1 | https://shizune.co/investors/profile/candace-johnson |
| Jacopo Losso | Director of Secretariat | 0 | https://shizune.co/investors/profile/jacopo-losso |
| Pablo Hernández | IT Expert | 0 | https://shizune.co/investors/profile/pablo-hernndez |
| Selma Prodanovic | Board Member & Vice President | 0 | https://shizune.co/investors/profile/selma-prodanovic |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Proteotype Diagnostics | Proteotype Diagnostics providing cross-sectional snapshots, like a CT scan for your blood. | $575K | Grant | Jul 30, 2026 |  |
| Xeltis | A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M | Venture - Series Unknown | Jul 28, 2026 |  |
| Xeltis | A clinical-stage medical device company, Xeltis has developed the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves, for whichclinical trials are ongoing. Xeltis was formed through the merger of two Dutch/Swiss university spin-offs. It currently has operations in The Netherlands and in the USA. Xeltis’ investors include venture capital funds EQT Life Sciences, Kurma Partners, VI Partners and Ysios Capital as well as a number of private investors. In 2021, Xeltis secured a €15 million financing from the European Investment Bank and a €15 million funding from the European Innovation Council Accelerator (EIC) set up by the European Commission. | $23.3M | Venture - Series Unknown | Jul 28, 2026 |  |
| Sensity AI | The Visual Threat Intelligence Platform. Deep learning for monitoring and detecting #deepfakes. | $5.6M | Grant | Jul 17, 2026 |  |
| Syntetica | Syntetica is a materials technology and climate technology company that develops chemical recycling technology for synthetic textiles. It uses proprietary green chemistry to convert nylon textile waste into virgin-quality recycled polymers, enabling circular production for the textile, automotive, and industrial materials industries. Its mission isto decarbonize synthetic materials by making high-quality recycled feedstocks commercially viable.The company's proprietary chemical depolymerization process separates and recovers Nylon 6 and Nylon 6,6 from blended textile waste that would otherwise be difficult to recycle. The process operates under low-temperature, low-pressure conditions, removes dyes and finishes, and produces recycled raw materials that can be reintroduced into manufacturing without compromising quality. Syntetica's technology supports textile-to-textile recycling and is designed to reduce carbon emissions, landfill waste, and reliance on virgin fossil-based materials. | $30M | Series A | Jul 16, 2026 |  |
| Nanovel | Nanovel Ltd. is a pioneer in the field of autonomous harvesting of deep foliage tree fruit. Isaac Mazor , Founder and CEO and the Nanovel team of top notch experts in AI and robotics technologies, are driven by the enormous need for innivation in fresh fruit harvesting. Nanovel's proprietary solution combines AI, computer vision, machinelearning and proprietary robotics solutions, to enable autonomous tree fruit harvesting to become more productive, reliable and cost effective than hand harvesting | $2.9M | Grant | Jul 15, 2026 |  |
| e-peas | e-peas is a disruptive semiconductor company that enables the seamless operation of all connected nodes. The company is developing ultra-low-power high performances circuits such as energy harvester interfaces and microcontrollers that help companies make their IoT devices smarter and more energy-efficient by either prolonging battery life ormaking the devices live forever. e-peas also develops energy harvesting solutions which extend rechargeable batteries' life of portable devices by harvesting energy from solar, thermal, vibration, radiofrequency, and other sources. These solutions help industries to build products that free users and industries from a burden of replacing non-rechargeable batteriesThe company was founded in 2014 and is headquartered in Mont-saint-guibert, Brabant Wallon, Belgium. | $21.9M | Venture - Series Unknown | Jul 08, 2026 |  |
| VSORA | VSORA is an IP provider for chipmakers designing the latest generations of digital communications systems, like 5G. Our powerful multi-core DSP architecture eliminates the need for DSP co-processors to provide a level of flexibility achievable only with software programming. A new DSP development flow allows signal processing engineers and softwareengineers to share the same environment and source code, dramatically accelerating time-to-market. Their mission is to meet the technical challenges by providing a state-of-the-art DSP design process and boosting the DSP computing power while simultaneously optimizing power consumption and system performance, and reducing the silicon footprint. Based in France, the company was founded in 2015 by a team of highly qualified and accomplished DSP engineers with combined experience of more than 70 years. |  | Venture - Series Unknown | Jul 01, 2026 |  |
| iPremom | iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia. | $2.8M | Grant | Jun 30, 2026 |  |
| RarEarth | RarEarth paves the way for rare earth recycling | $2.8M | Grant | Jun 25, 2026 |  |

10 of 1,175 investments shown.

## Co-investors
- [European Innovation Council](https://shizune.co/investors/profile/eic-fund) — VC Fund, 114 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 16 deals together
- [Invest-NL](https://shizune.co/investors/profile/invest-nl) — VC Fund, 9 deals together
- [Quantonation](https://shizune.co/investors/profile/quantonation) — VC Fund, 9 deals together
- [EIC Accelerator](https://shizune.co/investors/profile/eic-accelerator) — VC Fund, 8 deals together
- [Crédit Mutuel Innovation](https://shizune.co/investors/profile/cm-cic-capital-innovation) — VC Fund, 7 deals together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does European Innovation Council invest in?

European Innovation Council invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Funding Round stage. Most of the 1,175 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact European Innovation Council?

Public channels for European Innovation Council include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at European Innovation Council?

The team at European Innovation Council includes Baybars Altuntas (Board Member), Candace Johnson (President) and Jacopo Losso (Director of Secretariat), among 21 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co